US FDA approves new antibacterial drug Zerbaxa
Zerbaxa is used to treat cUTI, including kidney infection (pyelonephritis)
Author
A Pricey Issue
As part of the ongoing revision of the National List of Essential Medicines (NLEM) 2011, the National Pharma Pricing Authority…
DRL closes acquisition of Habitrol brand from Novartis
Dr Reddy’s Laboratories (DRL) has closed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy…
Panacea Biotec in collaboration with Rising Pharmaceuticals
Under the terms of the agreement, Panacea Biotec shall receive an upfront research fee on signing as well as a milestone payment…
National conference on drug discovery and drug targeting in metabolic diseases
Date: December 22-23, 2014
Venue: Dr Bhanuben Nanavati College of Pharmacy, Vile Parle, Mumbai
FDA announces Pharmacy Compounding Advisory Committee members
The members are experts in pharmaceutical compounding and manufacturing, pharmacy, medicine, and pharmaceutical regulation
US FDA approves first pathogen reduction system to treat plasma
Intercept Blood System for plasma may be used to reduce pathogens in plasma derived from whole blood and plasma obtained by…
Strides Arcolab receives US FDA approval for Calcitriol Softgel capsules
Product to be launched shortly
Indo-Israel Innovation colloquium discusses strategic business opportunities
Technology and innovation synergies between India and Israel are immense and have become key focus areas as avenues of…